SCHEMBL23061350

SCHEMBL23061350

COC1(c2cc(C(C)C)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.34

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 17/20 0.34
▸ TACR3 P29371 2/20 0.34
▸ CCR2 P41597 1/20 0.33
▸ OPRM1 P35372 2/20 0.31
▸ OPRD1 P41143 2/20 0.31
▸ OPRK1 P41145 2/20 0.31
▸ OPRL1 P41146 2/20 0.31
▸ KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24454293 0.79 HDAC3 (0.40) OPRM1
SCHEMBL15723317 0.79 CCR2 (0.38) TACR1TACR3CCR2KCNH2
SCHEMBL23113569 0.78 TSHR (0.35) —
SCHEMBL22497913 0.78 NOTUM (0.44) —
SCHEMBL21610788 0.78 CCR2 (0.34) TACR1TACR3CCR2KCNH2
SCHEMBL29659847 0.78 NOTUM (0.44) —
SCHEMBL24454611 0.74 CCR2 (0.35) TACR1CCR2OPRM1
SCHEMBL21610790 0.73 CCR2 (0.33) TACR1TACR3CCR2
SCHEMBL21610813 0.73 CCR2 (0.36) TACR1TACR3CCR2
SCHEMBL10629252 0.73 TACR1 (0.39) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143596-A1 PESTICIDALLY ACTIVE DIAZINE-BISAMIDE COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-05-11 — — US disclosed
US-20230143596-A1 PESTICIDALLY ACTIVE DIAZINE-BISAMIDE COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-05-11 — — US disclosed
US-20220159958-A1 PESTICIDALLY ACTIVE DIAZINE-AMIDE COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2022-05-26 — — US disclosed
WO-2021037614-A1 PESTICIDALLY ACTIVE PYRAZINE-AMIDE COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2021-03-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143596-A1 PESTICIDALLY ACTIVE DIAZINE-BISAMIDE COMPOUNDS DDT, ACHE, NIT2 TACR1 2209/4885TACR3 709/4885CCR2 4467/4885
US-20220159958-A1 PESTICIDALLY ACTIVE DIAZINE-AMIDE COMPOUNDS DDT, ACHE, NIT2 TACR1 1874/4885TACR3 296/4885CCR2 4433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback